series-a
Stage
About
Endowave is a Galway-based medical device company developing the FlexABLATE transbronchial microwave ablation system to enable robotic-bronchoscopy-delivered, minimally invasive treatment of lung cancer. The system is undergoing clinical evaluation in Europe and the company is raising a Series A to pursue CE marking and US regulatory approval.
Explore Endowave's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.